// App-Quantinova.ai

626 : Quantitative Non‐invasive Assessment of Liver Disease in Preclinical Models Using Multiparametric MR Imaging: A Feasibility Study

Researchers

Presenter

  • Anna M. Hoy

Principal Investigators

  • Natasha McDonald

  • Ross Lennen

  • Maurits A. Jansen

  • Matteo Milanesi

  • Amy H. Herlihy

  • Timothy J. Kendall

  • William Mungall

  • Michael L. Gyngell

  • Rajarshi Banerjee

  • Robert L. Janiczek

  • Philip S. Murphy

  • Jonathan A. Fallowfield

Medical Centers

  • MRC/University of Edinburgh Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United Kingdom

  • BHF/University of Edinburgh Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, United Kingdom

  • Prespectum Diagnostics, Oxford, United Kingdom

  • Biomedical Research Resources, The University of Edinburgh, Edinburgh, United Kingdom

  • GlaxoSmithKline, Stevenage, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Nonalcoholic fatty liver disease

Biomarkers

  • Cancer antigen 15-3

Drug/Treatment

  • methionine

  • Choline bitartrate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved